Evidence map›Paper›PMID 29750804›Full record

ArticlePloS one2018

Temporal/compartmental changes in viral RNA and neuronal injury in a primate model of NeuroAIDS.

R Gilberto González, Robert Fell, Julian He, Jennifer Campbell, Tricia H Burdo, Patrick Autissier, Lakshmanan Annamalai, Faramarz Taheri, Termara Parker, Jeffrey D Lifson and 6 more

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

R Gilberto GonzálezDepartment of Radiology, Neuroradiology Division, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA, United States of America.
Robert FellDepartment of Radiology, Neuroradiology Division, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA, United States of America.
Julian HeDepartment of Radiology, Neuroradiology Division, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA, United States of America.
Jennifer CampbellBiology Department, Boston College, Chestnut Hill, MA, United States of America.
Tricia H BurdoBiology Department, Boston College, Chestnut Hill, MA, United States of America.
Patrick AutissierBiology Department, Boston College, Chestnut Hill, MA, United States of America.
Lakshmanan AnnamalaiNew England Primate Research Center, Southborough, MA, United States of America.
Faramarz TaheriNew England Primate Research Center, Southborough, MA, United States of America.
Termara ParkerDepartment of Radiology, Neuroradiology Division, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA, United States of America.
Jeffrey D LifsonAIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, United States of America.
Elkan F HalpernHarvard Medical School, Boston, MA, United States of America.
Mark VangelDepartment of Radiology, Neuroradiology Division, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA, United States of America.
Eliezer MasliahDepartment of Neurosciences, University of California at San Diego, La Jolla, CA, United States of America.
Susan V WestmorelandNew England Primate Research Center, Southborough, MA, United States of America.
Kenneth C WilliamsBiology Department, Boston College, Chestnut Hill, MA, United States of America.
Eva-Maria RataiDepartment of Radiology, Neuroradiology Division, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Charlestown, MA, United States of America.ORCID 0000-0001-9476-6207

Funding

ZETA CHAIN OF T CELL RECEPTOR INTERACTS W/ NEF OF SIV &HIV2P51RR000168 · NCRR · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROWLETT, JAMES K · 1985 to 2011
$139.3M
STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jennifer E Iudicello · 2001 to 2026
$50.4M
MONOCYTE TRAFFIC AND THE NEUROPATHOGENESIS OF AIDSR01NS040237 · NINDS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI Robert Blair, Woong-Ki Kim · 1999 to 2026
$11.4M
RESOURCE FOR NONHUMAN PRIMATE CELL DEPLETING ANTIBODIESR24RR016001 · NCRR · BETH ISRAEL DEACONESS MEDICAL CENTER · PI REIMANN, KEITH A. · 2000 to 2011
$8.1M
Mechanisms of Neuroprotection in HIV EncephalitisR01MH062962 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MASLIAH, ELIEZER · 2002 to 2016
$5.2M
Neuroimmune responses and therapeutics of alpha-synucleinopathies of the aging populationZIAAG000936 · NIA · NATIONAL INSTITUTE ON AGING · PI COOKSON, MARK · 2017 to 2025
$4.1M
MR Spectroscopy of SIV Brain InjuryR01NS050041 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI GONZALEZ, RAMON GILBERTO · 2005 to 2009
$3.4M
MICROGLIA AND SIV NEUROPATHOGENESISR01NS037654 · NINDS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WILLIAMS, KENNETH C · 1998 to 2008
$2.4M
Combined MRI/PET Imager for Simultaneous Acquisition of PET/MRI DataS10RR022976 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI JENKINS, BRUCE · 2007 to 2007
$2.0M
A Storage Area Network for Structural and Functional Image AnalysisS10RR023401 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI FISCHL, BRUCE · 2009 to 2009
$2.0M
Monocyte/macrophage traffic and peripheral nerve pathogenesisR01NS082116 · NINDS · TEMPLE UNIV OF THE COMMONWEALTH · PI BURDO, TRICIA HELEN · 2012 to 2016
$2.0M
SILICON GRAPHICS PRISM EXTREME 128P/1TBS10RR023043 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI SORENSEN, ALMA GREGORY · 2006 to 2006
$1.5M
CCR NIH HHS HHSN261200800001CNCI NIH HHS HHSN261200800001ENCRR NIH HHS K26 RR000168NCRR NIH HHS P51 RR000168NCRR NIH HHS R24 RR016001NCRR NIH HHS S10 RR019307NCRR NIH HHS S10 RR019933NCRR NIH HHS S10 RR021110NCRR NIH HHS S10 RR022976NCRR NIH HHS S10 RR023043NCRR NIH HHS S10 RR023401NIAID NIH HHS N01 AI040101NIH HHS MH59754NIH HHS MH62512NIH HHS R01MH62962NIH HHS R01NS040237NIH HHS R01NS050041NIH HHS R01NS082116NIH HHS R01NS37654NIH HHS R21NS059331NIH HHS RR00168NIH HHS S10RR019307NIH HHS S10RR019933NIH HHS S10RR021110NIH HHS S10RR022976NIH HHS S10RR023043NIH HHS S10RR023401NIMH NIH HHS P30 MH062512NIMH NIH HHS R01 MH062962NINDS NIH HHS R01 NS037654NINDS NIH HHS R01 NS040237NINDS NIH HHS R01 NS050041NINDS NIH HHS R01 NS082116NINDS NIH HHS R21 NS059331
6 · The paper itself

Abstract

Despite the advent of highly active anti-retroviral therapy HIV-associated neurocognitive disorders (HAND) continue to be a significant problem. Furthermore, the precise pathogenesis of this neurodegeneration is still unclear. The objective of this study was to examine the relationship between infection by the simian immunodeficiency virus (SIV) and neuronal injury in the rhesus macaque using in vivo and postmortem sampling techniques. The effect of SIV infection in 23 adult rhesus macaques was investigated using an accelerated NeuroAIDS model. Disease progression was modulated either with combination anti-retroviral therapy (cART, 4 animals) or minocycline (7 animals). Twelve animals remained untreated. Viral loads were monitored in the blood and cerebral spinal fluid, as were levels of activated monocytes in the blood. Neuronal injury was monitored in vivo using magnetic resonance spectroscopy. Viral RNA was quantified in brain tissue of each animal postmortem using reverse transcription polymerase chain reaction (RT-PCR), and neuronal injury was assessed by immunohistochemistry. Without treatment, viral RNA in plasma, cerebral spinal fluid, and brain tissue appears to reach a plateau. Neuronal injury was highly correlated both to plasma viral levels and a subset of infected/activated monocytes (CD14+CD16+), which are known to traffic the virus into the brain. Treatment with either cART or minocycline decreased brain viral levels and partially reversed alterations in in vivo and immunohistochemical markers for neuronal injury. These findings suggest there is significant turnover of replicating virus within the brain and the severity of neuronal injury is directly related to the brain viral load.

Indexed as

Acquired Immunodeficiency SyndromeMagnetic Resonance ImagingRNA, ViralSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusAnimalsAnti-Retroviral AgentsDisease Models, AnimalMacaca mulattaMinocyclineNeuronsAnti-Retroviral AgentsMinocyclineRNA, Viral

Identifiers

PMID29750804
PMCPMC5947913

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.